The effect of Shirazi thyme in the treatment of fatty liver
Not Applicable
- Conditions
- on alcoholic fatty liver.Non alcoholic fatty liver diseaseK 76.0
- Registration Number
- IRCT2015120925447N1
- Lead Sponsor
- Vice chancellor for research, Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
signed informed consent; age between 20 to 65 years old; BMI : 18 - 35; evidence of fatty liver in sonography; ALT equal or more than 45 in male and equal or more than 29 in female.
Exclusion criteria: pregnancy; lactation; alcohol consumption; diabetes mellitus; history of allergic reaction to Thyme; acute or chronic hepatic disease; treated or untreated malignancy; consumption of hepatotoxic drugs during six months ago or less; consumption of drugs with effect on the biochemical markers of this study during three months ago or less; hyper or hypothyroidism; renal insufficiency (Cr > 1.5 ).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Alaninaminotransferase. Timepoint: Before intervention and three months after intervention. Method of measurement: Blood sampling.;Grade of fatty liver. Timepoint: Before intervention and three months after intervention. Method of measurement: Ultrasonography.
- Secondary Outcome Measures
Name Time Method